These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34758065)

  • 1. Frailty and Depression in Late Life: A High-Risk Comorbidity With Distinctive Clinical Presentation and Poor Antidepressant Response.
    Brown PJ; Ciarleglio A; Roose SP; Montes Garcia C; Chung S; Fernandes S; Rutherford BR
    J Gerontol A Biol Sci Med Sci; 2022 May; 77(5):1055-1062. PubMed ID: 34758065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty Worsens Antidepressant Treatment Outcomes in Late Life Depression.
    Brown PJ; Ciarleglio A; Roose SP; Garcia CM; Chung S; Alvarez J; Stein A; Gomez S; Rutherford BR
    Am J Geriatr Psychiatry; 2021 Sep; 29(9):944-955. PubMed ID: 33388223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of late life depressive symptoms on the trajectories of insomnia symptoms during antidepressant treatment.
    Gebara MA; Kasckow J; Smagula SF; DiNapoli EA; Karp JF; Lenze EJ; Mulsant BH; Reynolds CF
    J Psychiatr Res; 2018 Jan; 96():162-166. PubMed ID: 29069615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.
    Tang VM; Yu D; Weissman CR; Jones BDM; Wang G; Sloan ME; Blumberger DM; Daskalakis ZJ; Le Foll B; Voineskos D
    J Affect Disord; 2023 Oct; 339():691-697. PubMed ID: 37467796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.
    Gueorguieva R; Mallinckrodt C; Krystal JH
    Arch Gen Psychiatry; 2011 Dec; 68(12):1227-37. PubMed ID: 22147842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression is associated with self-rated frailty in older adults from an outpatient clinic: a prospective study.
    Aprahamian I; Suemoto CK; Lin SM; de Siqueira ASS; Biella MM; de Melo BAR; Jacob-Filho W
    Int Psychogeriatr; 2019 Mar; 31(3):425-434. PubMed ID: 30099972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Brown ES; Sayed N; Van Enkevort E; Kulikova A; Nakamura A; Khan DA; Ivleva EI; Sunderajan P; Bender BG; Holmes T
    J Allergy Clin Immunol Pract; 2018; 6(5):1604-1612. PubMed ID: 29409976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy outcomes in the MDD-1 India study: First episode major depressive disorder outcomes in antidepressant-treated real-world patients in India.
    Andrade C; De Sousa A; Shah N
    J Psychopharmacol; 2020 Oct; 34(10):1098-1104. PubMed ID: 32684093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative Antidepressant Effect of Chamomile (
    Amsterdam JD; Li QS; Xie SX; Mao JJ
    J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids for depression in adults.
    Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol.
    Pigott HE; Kim T; Xu C; Kirsch I; Amsterdam J
    BMJ Open; 2023 Jul; 13(7):e063095. PubMed ID: 37491091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
    Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
    Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.